BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/11/2014 9:05:00 AM | Browse: 1082 | Download: 1104
 |
Received |
|
2013-02-17 13:57 |
 |
Peer-Review Started |
|
2013-02-18 08:51 |
 |
To Make the First Decision |
|
2013-03-11 14:52 |
 |
Return for Revision |
|
2013-03-18 09:36 |
 |
Revised |
|
2013-03-25 23:09 |
 |
Second Decision |
|
2013-04-10 16:55 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2013-04-11 05:13 |
 |
Articles in Press |
|
|
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2013-05-15 17:18 |
 |
Publish the Manuscript Online |
|
2013-06-06 10:41 |
Category |
Medicine, General & Internal |
Manuscript Type |
Editorial |
Article Title |
Uric acid and chronic kidney disease: A time to act?
|
Manuscript Source |
|
All Author List |
Gianni Bellomo |
Funding Agency and Grant Number |
|
Corresponding Author |
Gianni Bellomo, MD, Department of Nephrology, San Giovanni Battista Hospital, Via Arcamone 1, 06034 Foligno, Italy. assidial@tin.it |
Key Words |
Uric acid; Urate; Chronic kidney disease; Allopurinol; Febuxostat; Diabetes; Renal transplantation |
Core Tip |
The evidence presented so far, derived from experimental, epidemiological, and a few, small, intervention studies, points towards a role for uric acid in the progression of chronic kidney disease and deterioration of renal function. However, conclusive proof, such as that coming from a randomized clinical trial, is lacking. Finally we will briefly discuss the challenges of a trial of uric-acid-lowering treatment, and the recent suggestions on how to conduct such a trial. |
Publish Date |
2013-06-06 10:41 |
Citation |
Bellomo G. Uric acid and chronic kidney disease: A time to act? World J Nephrol 2013; 2(2): 7-25 |
URL |
http://www.wjgnet.com/2220-6124/full/v2/i2/17.htm |
DOI |
http://dx.doi.org/10.5527/wjn.v2.i2.17 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345